These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11232632)

  • 1. Clinical competency statement: implantation and follow-up of cardioverter defibrillators.
    Curtis AB; Langberg JJ; Tracy CM;
    J Cardiovasc Electrophysiol; 2001 Feb; 12(2):280-4. PubMed ID: 11232632
    [No Abstract]   [Full Text] [Related]  

  • 2. Addendum to the clinical competency statement: training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices.
    Day JD; Curtis AB; Epstein AE; Goldschlager NF; Olshansky B; Reynolds DW; Wang PJ;
    Heart Rhythm; 2005 Oct; 2(10):1161-3. PubMed ID: 16188603
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical competency statement: Training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices.
    Curtis AB; Ellenbogen KA; Hammill SC; Hayes DL; Reynolds DW; Wilber DJ; Cain ME
    Heart Rhythm; 2004 Sep; 1(3):371-5. PubMed ID: 15851187
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recommendations on the implantation and surveillance of implantable defibrillators].
    Chauvin M; Frank R; Le Heuzey JY; Barnay C; Cazeau S; Djiane P; Guenoun M; Leenhardt A; Mabo P; Sadoul N;
    Arch Mal Coeur Vaiss; 2004 Sep; 97(9):915-9. PubMed ID: 15521486
    [No Abstract]   [Full Text] [Related]  

  • 5. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Wilkoff BL; Fauchier L; Stiles MK; Morillo CA; Al-Khatib SM; Almendral J; Aguinaga L; Berger RD; Cuesta A; Daubert JP; Dubner S; Ellenbogen KA; Estes NA; Fenelon G; Garcia FC; Gasparini M; Haines DE; Healey JS; Hurtwitz JL; Keegan R; Kolb C; Kuck KH; Marinskis G; Martinelli M; Mcguire M; Molina LG; Okumura K; Proclemer A; Russo AM; Singh JP; Swerdlow CD; Teo WS; Uribe W; Viskin S; Wang CC; Zhang S;
    Europace; 2016 Feb; 18(2):159-83. PubMed ID: 26585598
    [No Abstract]   [Full Text] [Related]  

  • 6. Implantable cardioverter-defibrillator leads: design, diagnostics, and management.
    Swerdlow CD; Ellenbogen KA
    Circulation; 2013 Oct; 128(18):2062-71, 1-9. PubMed ID: 24166415
    [No Abstract]   [Full Text] [Related]  

  • 7. Heart Rhythm UK position statement on clinical indications for implantable cardioverter defibrillators in adult patients with familial sudden cardiac death syndromes.
    Garratt CJ; Elliott P; Behr E; Camm AJ; Cowan C; Cruickshank S; Grace A; Griffith MJ; Jolly A; Lambiase P; McKeown P; O'Callagan P; Stuart G; Watkins H;
    Europace; 2010 Aug; 12(8):1156-75. PubMed ID: 20663787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical practice guidelines of the Sociedad Española de Cardiología on the automatic implantable defibrillator].
    Pérez-Villacastín J; Carmona Salinas JR; Hernández Madrid A; Marín Huerta E; Merino Llorens JL; Ormaetxe Merodio J; Moya i Mitjans A
    Rev Esp Cardiol; 1999 Dec; 52(12):1083-104. PubMed ID: 10659655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The implantable cardioverter defibrillator revolution continues.
    Zipes DP
    Mayo Clin Proc; 1994 Apr; 69(4):395-6. PubMed ID: 8170186
    [No Abstract]   [Full Text] [Related]  

  • 11. Implantable Cardioverter-Defibrillator-Cybersecurity.
    Alexander B; Neira V; Campbell D; Crystal E; Simpson C; Enriquez A; Chacko S; Abdollah H; Redfearn D; Baranchuk A
    Circ Arrhythm Electrophysiol; 2020 Mar; 13(3):e008261. PubMed ID: 32078370
    [No Abstract]   [Full Text] [Related]  

  • 12. Implantable cardioverter-defibrillators.
    DiMarco JP
    N Engl J Med; 2003 Nov; 349(19):1836-47. PubMed ID: 14602883
    [No Abstract]   [Full Text] [Related]  

  • 13. Implantable cardioverter defibrillators in cardiovascular practice: report of the policy conference of the North American Society of Pacing and Electrophysiology.
    J Interv Cardiol; 1991; 4(3):211-20. PubMed ID: 10160988
    [No Abstract]   [Full Text] [Related]  

  • 14. Canadian Cardiovascular Society/Canadian Heart Rhythm Society 2016 Implantable Cardioverter-Defibrillator Guidelines.
    Bennett M; Parkash R; Nery P; Sénéchal M; Mondesert B; Birnie D; Sterns LD; Rinne C; Exner D; Philippon F; Campbell D; Cox J; Dorian P; Essebag V; Krahn A; Manlucu J; Molin F; Slawnych M; Talajic M
    Can J Cardiol; 2017 Feb; 33(2):174-188. PubMed ID: 28034580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Wilkoff BL; Fauchier L; Stiles MK; Morillo CA; Al-Khatib SM; Almendral J; Aguinaga L; Berger RD; Cuesta A; Daubert JP; Dubner S; Ellenbogen KA; Mark Estes NA; Fenelon G; Garcia FC; Gasparini M; Haines DE; Healey JS; Hurtwitz JL; Keegan R; Kolb C; Kuck KH; Marinskis G; Martinelli M; McGuire M; Molina LG; Okumura K; Proclemer A; Russo AM; Singh JP; Swerdlow CD; Teo WS; Uribe W; Viskin S; Wang CC; Zhang S
    Heart Rhythm; 2016 Feb; 13(2):e50-86. PubMed ID: 26607062
    [No Abstract]   [Full Text] [Related]  

  • 16. [Implantable cardioverter defibrillator].
    Tanaka S; Ikeshita M; Shoji T
    Kokyu To Junkan; 1993 Apr; 41(4):357-63. PubMed ID: 8516574
    [No Abstract]   [Full Text] [Related]  

  • 17. Infrequent physician use of implantable cardioverter-defibrillators risks patient safety.
    Lyman S; Sedrakyan A; Do H; Razzano R; Mushlin AI
    Heart; 2011 Oct; 97(20):1655-60. PubMed ID: 21795298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practice advisory for the perioperative management of patients with cardiac rhythm management devices: pacemakers and implantable cardioverter-defibrillators: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Rhythm Management Devices.
    American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Rhythm Management Devices
    Anesthesiology; 2005 Jul; 103(1):186-98. PubMed ID: 15983472
    [No Abstract]   [Full Text] [Related]  

  • 19. The subcutaneous implantable cardioverter and defibrillator: advantages, limitations and future directions.
    Verma N; Rhyner J; Knight BP
    Expert Rev Cardiovasc Ther; 2015; 13(9):989-99. PubMed ID: 26308601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Troubleshooting implantable cardioverter-defibrillator related problems.
    van Erven L; Schalij MJ
    Heart; 2008 May; 94(5):649-60. PubMed ID: 18411360
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.